Cargando…

Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study

CONTEXT: Cyavanaprāśa (CP) is an Ayurvedic immune booster formulation that confers vigor and vitality while delaying the ageing process. Benefits of CP have been studied widely in adult population. OBJECTIVES: Current study assessed beneficial effects of CP on health and immunity related parameters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Arun, Kumar, Sunil, Dole, Sanjeeva, Deshpande, Shailesh, Deshpande, Vaishali, Singh, Sudha, Sasibhushan, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566825/ https://www.ncbi.nlm.nih.gov/pubmed/28867858 http://dx.doi.org/10.4103/asl.ASL_8_17

Ejemplares similares

Evaluation of Health Promotion In Elderly People Through Cyavanaprasa
por: Dalai, Sujit Kumar, et al.
Publicado: (2005)

Prospective, Randomized, Open-Label, Blinded End Point, Two-Arm, Comparative Clinical Study to Evaluate the Efficacy and Safety of a Fixed Ayurvedic Regimen (FAR) as Add-on to Conventional Treatment in the Management of Mild and Moderate COVID-19 Patients
por: Gupta, Arun, et al.
Publicado: (2021)

Effect of panchakarma and Ayurvedic treatment in postpartum rheumatoid arthritis (amavata): A case study
por: Deshpande, Shailesh V., et al.
Publicado: (2017)

A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy
por: Deshpande, Alka, et al.
Publicado: (2016)

Conservative management of acute prolapsed inter-vertebral disc with ayurveda: A case report
por: Deshpande, Shailesh V., et al.
Publicado: (2022)

Comparative effect of composite management of type II diabetes mellitus with induced emesis and Varadi Ghanavati: A pilot clinical study
por: Deshpande, Shailesh V., et al.
Publicado: (2023)

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents
por: Paradis, Erin M., et al.
Publicado: (2021)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study
por: Liang, Ying, et al.
Publicado: (2016)

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
por: Starling, Amaal J, et al.
Publicado: (2018)

Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients
por: Yamagami, Jun, et al.
Publicado: (2022)

Comparative evaluation of qualitative performance of technical human resource in school eye health program
por: Dole, Kuldeep S, et al.
Publicado: (2021)

Can the postoperative follow-up visit be deferred up to four weeks after an uneventful cataract surgery? - A randomized controlled trial
por: Deshpande, Rahul, et al.
Publicado: (2021)

Effects on ocular aberration and contrast sensitivity after implantation of spherical and aspherical monofocal intraocular lens - A comparative study
por: Deshpande, Rahul, et al.
Publicado: (2022)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
por: Honda, Yasushi, et al.
Publicado: (2017)

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
por: Wirth, Lori J., et al.
Publicado: (2021)

Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
por: Matsumura, Tsuyoshi, et al.
Publicado: (2022)

Impact of Yoga and Meditation on Cellular Aging in Apparently Healthy Individuals: A Prospective, Open-Label Single-Arm Exploratory Study
por: Tolahunase, Madhuri, et al.
Publicado: (2017)

Response to comment on: Comparative evaluation of qualitative performance of technical human resource in school eye health program
por: Dole, Kuldeep S, et al.
Publicado: (2021)

A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
por: Vuppalanchi, Raj, et al.
Publicado: (2021)

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
por: Hasegawa, Hirotaka, et al.
Publicado: (2022)

Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial
por: Cui, Yayun, et al.
Publicado: (2022)

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
por: Deng, Li-Juan, et al.
Publicado: (2023)

Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA)
por: Ozeki, Michio, et al.
Publicado: (2019)

Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension　― A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study ―
por: Sakurai, Satomi, et al.
Publicado: (2021)

Ocular outcomes and comorbidities in preterm infants enrolled for retinopathy of prematurity screening: A cohort study from western India
por: Kulkarni, Sucheta, et al.
Publicado: (2019)

A clinical study to assess feasibility, acceptance, and outcome of multifocal intraocular lens in patients with bilateral immature cataract at a tertiary eye care institute
por: Deshpande, Rahul, et al.
Publicado: (2020)

Comparative study of anatomical and functional recovery of eye along with patient satisfaction score after small-incision cataract surgery and phacoemulsification cataract surgery
por: Dole, Kuldeep, et al.
Publicado: (2022)

A comparative clinical study of postoperative care by teleophthalmology and in-person consultation at hospital outpatient department after an uncomplicated cataract surgery
por: Dole, Kuldeep, et al.
Publicado: (2023)

Erratum to “Impact of Yoga and Meditation on Cellular Aging in Apparently Healthy Individuals: A Prospective, Open-Label Single-Arm Exploratory Study”
por: Tolahunase, Madhuri, et al.
Publicado: (2017)

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
por: Marty, Francisco M., et al.
Publicado: (2014)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
por: Hamauchi, Satoshi, et al.
Publicado: (2019)

Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
por: Song, Zhengbo, et al.
Publicado: (2022)

Establishing rural and urban health training centers in AYUSH teaching institutes: A pivotal step for building community interface
por: Deshpande, Shailesh Rajaram
Publicado: (2015)

An open-label study of oral acetazolamide for the prevention of antipsychotic associated weight gain
por: Priyamkari, Anupama, et al.
Publicado: (2023)

High energy, double pass helium plasma dermal resurfacing: A prospective, multicenter, single‐arm clinical study
por: Holcomb, J. David, et al.
Publicado: (2022)

Response to: Comparison of clinical outcomes, patient, and surgeon satisfaction following topical versus peribulbar anesthesia for phacoemulsification: A randomized controlled trial
por: Dole, Kuldeep, et al.
Publicado: (2015)

The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma
por: Chen, Wenming, et al.
Publicado: (2022)

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
por: Zimmer, Lisa, et al.
Publicado: (2015)

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
por: Jung, Ki Sun, et al.
Publicado: (2018)

MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)
por: Wirth, Lori J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e3uv405o6183oo9u5o40jbg6e3